CLINICAL_TRIALS
trial_result
· 2022-06-08
Clinical Trial Update: Effects of Galantamine on Cognition [Phase 2]
Summary
Phase 2 trial investigating the effects of galantamine on cognition in schizophrenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2022-06-08